We are live on ! Find out more
Aperio Group

Aperio Group Portfolio holdings

AUM $33.8B Turnover 6.32%
1-Year Est. Return 31.46%
This Fund
S&P 500
This Quarter Est. Return
+15.94%
1 Year Est. Return
+31.46%
3 Year Est. Return
+70.41%
5 Year Est. Return
+146.06%
10 Year Est. Return
–
AUM
$33.8B
AUM Growth
+$4.19B
Cap. Flow
+$264M
Cap. Flow %
0.78%
Top 10 Hldgs %
21.76%
Holding
2,483
New
104
Increased
1,329
Reduced
987
Closed
53
Avg Time Held
4.6 years
Top 10 Avg Time Held
3.4 years
Top 20 Avg Time Held
3.1 years

Top Buys

Rank Stock Value
1
UL icon
Unilever
UL
+$52.4M
2
TSLA icon
Tesla
TSLA
+$42.1M
3
MSFT icon
Microsoft
MSFT
+$16.9M
4
DIS icon
Walt Disney
DIS
+$14.5M
5
MS icon
Morgan Stanley
MS
+$11.9M

Top Sells

Rank Stock Value
1
UN icon
Unilever NV New York Registry Shares
UN
+$48.8M
2
T icon
AT&T
T
+$25.4M
3
JNJ icon
Johnson & Johnson
JNJ
+$20M
4
AMZN icon
Amazon
AMZN
+$15.7M
5
BIIB icon
Biogen
BIIB
+$12.3M

Sector Composition

Rank Sector Weight
1 Technology 25.68%
2 Financials 13.75%
3 Healthcare 13.35%
4 Consumer Discretionary 11.59%
5 Communication Services 9.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
SRNE
2251
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$248K ﹤0.01%
36,362
-6,855
-16% -$55.1K
2020 Q1
3 quarters
DT icon
2252
Dynatrace
DT
$18.7B
$246K ﹤0.01%
+5,691
New +$226K
2020 Q4
0 quarters
KOD icon
2253
Kodiak Sciences
KOD
$5.5B
$246K ﹤0.01%
+1,676
New +$187K
2020 Q4
0 quarters
VRRM icon
2254
Verra Mobility
VRRM
$447M
$246K ﹤0.01%
18,347
+4,005
+28% +$47.1K
2020 Q2
2 quarters
CALX icon
2255
Calix
CALX
$2.31B
$244K ﹤0.01%
+8,190
New +$202K
2020 Q4
0 quarters
DCOM icon
2256
DELISTED
Dime Community Bancshares
DCOM
$244K ﹤0.01%
15,490
-701
-4% -$9.8K
2014 Q3
25 quarters
OMER icon
2257
Omeros
OMER
$1.18B
$243K ﹤0.01%
17,029
+2,559
+18% +$31.3K
2020 Q1
3 quarters
XRN icon
2258
Chiron Real Estate Inc
XRN
$382M
$242K ﹤0.01%
3,713
+1,021
+38% +$70.3K
2019 Q4
4 quarters
TAC icon
2259
TransAlta
TAC
$4.27B
$241K ﹤0.01%
31,739
-1,509
-5% -$10.1K
2014 Q1
27 quarters
RCKT icon
2260
Rocket Pharmaceuticals
RCKT
$243M
$239K ﹤0.01%
+4,351
New +$159K
2020 Q4
0 quarters
GWX icon
2261
State Street SPDR S&P International Small Cap ETF
GWX
$905M
$237K ﹤0.01%
6,704
– –
2020 Q3
1 quarter
MESO icon
2262
Mesoblast
MESO
$1.67B
$236K ﹤0.01%
13,912
-1,999
-13% -$49.2K
2020 Q1
3 quarters
APLS icon
2263
DELISTED
Apellis Pharmaceuticals
APLS
$235K ﹤0.01%
+4,113
New +$174K
2020 Q4
0 quarters
EBSB
2264
DELISTED
Meridian Bancorp, Inc.
EBSB
$235K ﹤0.01%
15,787
-679
-4% -$9.03K
2019 Q2
6 quarters
CRVL icon
2265
CorVel
CRVL
$4.07B
$233K ﹤0.01%
+6,597
New +$205K
2020 Q4
0 quarters
PGEN icon
2266
Precigen
PGEN
$2.37B
$233K ﹤0.01%
22,885
-4,084
-15% -$26.5K
2019 Q2
6 quarters
XBIT icon
2267
XBiotech
XBIT
$60.7M
$233K ﹤0.01%
14,909
+2,967
+25% +$54.7K
2020 Q2
2 quarters
LADR icon
2268
Ladder Capital
LADR
$1.14B
$232K ﹤0.01%
23,760
-2,199
-8% -$18.7K
2018 Q1
11 quarters
RCUS icon
2269
Arcus Biosciences
RCUS
$2.49B
$231K ﹤0.01%
+8,909
New +$216K
2020 Q4
0 quarters
GHG icon
2270
GreenTree Hospitality
GHG
$96.7M
$230K ﹤0.01%
17,201
+2,090
+14% +$27.5K
2020 Q1
3 quarters
VCEL icon
2271
Vericel Corp
VCEL
$2.09B
$229K ﹤0.01%
+7,429
New +$177K
2020 Q4
0 quarters
SHOE icon
2272
Shoe Station Group
SHOE
$360M
$228K ﹤0.01%
11,636
-504
-4% -$9.01K
2020 Q3
1 quarter
SRCE icon
2273
1st Source
SRCE
$2.06B
$227K ﹤0.01%
5,635
-4,864
-46% -$178K
2020 Q2
2 quarters
AKO.B icon
2274
Embotelladora Andina Series B
AKO.B
$4.73B
$226K ﹤0.01%
15,143
-2,795
-16% -$37.7K
2014 Q1
27 quarters
STNG icon
2275
Scorpio Tankers
STNG
$4.19B
$225K ﹤0.01%
20,083
-3,896
-16% -$43.1K
2020 Q1
3 quarters
89 90
91
92 93

Similar funds

Optiver US
Optiver US Chicago, Illinois $50B AUM 53.51% 1-Year Est. Return
Carillon Tower Advisers
Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return
Greenwoods Asset Management
Greenwoods Asset Management Grand Cayman, Cayman Islands $4.35B AUM 149.74% 1-Year Est. Return
Columbus Circle Investors
Columbus Circle Investors $2.28B AUM 135.57% 1-Year Est. Return
SVA Wealth Management
SVA Wealth Management Madison, Wisconsin $1.15B AUM 22.3% 1-Year Est. Return
LCM
Lomas Capital Management New York $1.04B AUM 24.59% 1-Year Est. Return
Howard Capital Management (New York)
Howard Capital Management (New York) New York $891M AUM 34.82% 1-Year Est. Return
Bainco International Investors
Bainco International Investors Boston, Massachusetts $873M AUM 30.2% 1-Year Est. Return

Aperio Group's Q4 2020 Portfolio in Review

As of Q4 2020, Aperio Group held 2,483 positions worth $33.8B, up 14% from $29.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Aperio Group's Q4 2020 filing shows 104 new, 1,329 increased, 987 reduced and 53 closed positions. Its largest new stake was Concentrix: 51,604 shares worth $5.09M. The largest sale was Unilever NV New York Registry Shares, an estimated $48.8M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Financials and Healthcare.

  • Aperio Group's largest Q4 2020 buy was Concentrix: 51,604 shares worth $5.09M.
  • Aperio Group added most to Unilever in Q4 2020, an estimated $52.4M increase.
  • Aperio Group's biggest Q4 2020 reduction was AT&T, cutting an estimated $25.4M.
  • Aperio Group fully exited Unilever NV New York Registry Shares in Q4 2020, selling an estimated $48.8M.
  • Aperio Group's ten largest holdings make up 22% of its $33.8B portfolio in Q4 2020.
  • Aperio Group opened 104 new positions and closed 53 in Q4 2020.
  • Aperio Group's portfolio value rose 14% quarter-over-quarter to $33.8B.

Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.